MIcrobiome Analysis of Chronically Constipated Versus Non-constipated Populations for Detection of Novel Molecular Entities With Therapeutic Potential
MIcrobiome Analysis of Chronically Constipated Versus Non-constipated Populations for Detection of Novel Molecular Entities With Therapeutic Potential
This study intends to evaluate the microbiome of chronically constipated patients as compared to those with a non-constipated gastrointestinal system.
Biogeographically accurate microbiome sampling using the HyGIeaCare platform and an evolutionary biology informed learning platform will allow an improved discovery of bacterially derived novel molecular entities with therapeutic potential for chronic constipation. This approach intends to enhance our ability to understand the gut microbiome and use it towards developing therapeutic solutions, in comparison to traditional collection methods and taxonomic-based data analysis approaches.
Inclusion Criteria:
For chronically constipated patients - Diagnosis of functional constipation by Modified Rome IV Diagnostic Criteria.
Exclusion Criteria:
Patient has functional bowel disorders characterized by alternating bowel habits (diarrhea/constipation).
Patient has any other condition that, in the opinion of the investigator, may adversely affect the compliance or safety of the patient or would limit the patient's ability to complete the study.
Current, or recent (within three months) antibiotic usage
Patient has any of the contraindications listed below:
Cardiac: Congestive heart failure (NYHA class III or IV or EF <50%)
GI: Intestinal perforation, carcinoma of the rectum, fissures or fistula, severe hemorrhoids, abdominal hernia, recent colon or rectal surgery, or abdominal surgery
GU: Renal insufficiency (CC < 60 ml/min/173m2), cirrhosis with ascites
Abdominal surgery within the last 6 months
Pregnancy